IFP Advisors’s TriSalus Life Sciences TLSI Stock Holding History

IFP Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$5	–	5035
2025 Q3	$5	Buy	+1	New	+$5	﹤0.01%	4807

Other funds holding TLSI

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's TLSI Position: Q4 2025 in Review

IFP Advisors sold out of TriSalus Life Sciences (TLSI) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

IFP Advisors first reported a position in TLSI in Q3 2025 and held it in 1 quarter. The position peaked at $5 in Q3 2025. 67 funds tracked by Wall St. Rank hold TLSI as of Q4 2025.

IFP Advisors reported no remaining TriSalus Life Sciences position as of Q4 2025 after selling out during the quarter.
IFP Advisors sold 1 TriSalus Life Sciences share in Q4 2025, an estimated $5.
IFP Advisors first reported a position in TriSalus Life Sciences in Q3 2025 and held it in 1 quarter.
IFP Advisors's TriSalus Life Sciences position peaked at $5 in Q3 2025.
67 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2025.

Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.